Insider Trading History of Sullivan James J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Sullivan James J since 2006. The trader's CIK number is 1218869. At the time of the last reporting, Sullivan James J was the Senior VP and Secret of Nextgen Healthcare, Inc.. (stock ticker symbol NXGN). Also see all insider trading activities at Nextgen Healthcare, Inc..

Note that in the past SULLIVAN JAMES J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Nextgen Healthcare, Inc. (QSII) by Sullivan James J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 QSII 0 $0 2,000 $88,040 4,000 $128,639

Yearly summary of insider trading at Trizetto Group Inc (TZIX) by Sullivan James J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 TZIX 0 $0 5,000 $105,500 0 $0
2006 TZIX 0 $0 55,000 $986,480 55,000 $664,400


Insider trading activities at 2 companies by Sullivan James J:

1. Nextgen Healthcare, Inc. (QSII)

2. Trizetto Group Inc (TZIX)

Table 1. Insider trading of Nextgen Healthcare, Inc. (QSII) by Sullivan James J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-02-13 QSII Sale 2,000 44.02 88,040
2012-02-13 QSII Option Ex 4,000 32.16 128,639

Table 2. Insider trading of Trizetto Group Inc (TZIX) by Sullivan James J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-02-16 TZIX Sale 5,000 21.10 105,500
2006-02-15 TZIX Sale 55,000 17.94 986,480
2006-02-15 TZIX Option Ex 55,000 12.08 664,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sullivan James J (Senior VP and Secret of Nextgen Healthcare, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.